Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 5/2004

01-05-2004 | Editorial

Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia

Authors: Victor L. Yu, Nina Singh

Published in: Intensive Care Medicine | Issue 5/2004

Login to get access

Excerpt

Controversies regarding the management, optimal use of antibiotic therapy, and diagnostic methodology have spawned an accumulating body of literature attempting to address these issues. Over 300 studies have been published in peer-review journals in the past 8 years dealing with management of ventilator-associated pneumonia. A frustrating dilemma, nevertheless, is that there is no consensus on even the precise definition of ventilator-associated pneumonia. The greatest uncertainty deals with the necessity for invasive diagnostic methods, specifically quantitative cultures from the lung by bronchoalveolar lavage (BAL) or protected specimen brush (PSB). We do not wish to become embroiled in this controversy; however, it must be conceded that despite numerous labor-intensive and rigorous trials by respected investigators, no consensus exists on the necessity of such procedures, and routine use of these procedures have not widely been adopted in intensive care units. …
Literature
1.
Chinsky KD (2002) Ventilator-associated pneumonia: is there any gold in these standards? Chest 122:1883–1884CrossRefPubMed
2.
Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505–511PubMed
3.
Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew RD, Suter PM (1991) Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 143:1121–1129
4.
Dupont H, Montravers P, Gauzit R, Veber B, Pouriat JL (2003) Outcome of postperative pneumonia in the Eole study. Intensive Care Med 29:179–188PubMed
5.
Kolleff MH (2003) Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate. Intensive Care Med 29:147–149PubMed
6.
Chastre J, Fagon JY, Soler P, et al (1988) Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of broncoalveolar lavage and the protected specimen brush. Am J Med 85:499–506PubMed
7.
Dennesen PWJ, van der Ven AJAM, Kessels AJH, et al (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Crit Care Med 163:1371–1375
8.
Bergmans DCJJ, Bonten MJM, Gaillard CA, van Thiel FH, van der Geest S, de Leeuw PW, Stobberingh EE (1997) Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 39:527–535CrossRefPubMed
9.
Singh N, Falestiny MN, Rogers P, Reed MJ, Pularski J, Norris R, Yu VL (1998) Pulmonary infiltrates in the surgical ICU. Chest 114:1129–1136PubMed
10.
Kim JH, Gallis HA (1989) Observations on spiraling empiricism: its causes, allure, and perils, with particular reference to antibiotic therapy. Am J Med 87:201–206PubMed
11.
12.
Fagon J-Y, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl J-L, Sollet J-P, Tenaillon A, for the VAP Trial Group (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 132:621–630PubMed
13.
Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, Palizas F, Menga G, Rios F, Apezteguia C (2003) Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31:676–682CrossRefPubMed
14.
Fartoukh M, Maitre B, Honore S, Cerf C, Zahar JR, Brun-Buisson C (2003) Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 168:173–179CrossRefPubMed
15.
Spear S, Bowen HK (1999) Decoding the DNA of the Toyota Production System. Harvard Business Review, pp 97–106
Metadata
Title
Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia
Authors
Victor L. Yu
Nina Singh
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 5/2004
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-004-2201-0

Other articles of this Issue 5/2004

Intensive Care Medicine 5/2004 Go to the issue

Original

Myocardial redox state during coronary artery bypass grafting assessed with microdialysis

Original

Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era

Original

Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia

Brief Report

Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia

Editorial

Breath by breath, spontaneously or mechanically supported: lessons from biphasic positive airway pressure (BIPAP)

Brief Report

Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units